Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Cardiac and multiorgan transplantation for end-stage congenital heart disease.
Neither Lys- and DAP-type peptidoglycans stimulate mouse or human innate immune cells via Toll-like receptor 2.
Phosphodiesterase I
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cardiac and multiorgan transplantation for end-stage congenital heart disease.
Cardiac and multiorgan transplantation for end-stage congenital heart disease. Mayo Clin Proc. 2014 Apr; 89(4):478-83.
View in:
PubMed
subject areas
Academic Medical Centers
Adolescent
Adult
Child
Child, Preschool
Cohort Studies
Confidence Intervals
Critical Illness
Female
Follow-Up Studies
Graft Rejection
Graft Survival
Heart Defects, Congenital
Heart Failure
Heart Transplantation
Humans
Infant
Kidney Transplantation
Liver Transplantation
Male
Minnesota
Retrospective Studies
Risk Assessment
Survival Rate
Treatment Outcome
Young Adult
authors with profiles
Harold M Burkhart